{"id":"W3031773775","doi":"10.1200/jco.2020.38.15_suppl.8541","title":"DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and high-risk (HR) cytogenetics.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Internal medicine; Cytogenetics; Adverse effect; Nausea; Gastroenterology; Refractory (planetary science); Oncology; Lenalidomide; Surgery; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001309408,0.0003639383,0.0009865424,0.0002592314,0.000161765,0.0005115767,0.0004956182,0.0005058945,0.001807463],"category_scores_gemma":[0.0009128777,0.0002508225,0.0008291008,0.0003194033,0.0003047946,0.0006052944,0.0004555143,0.0009852791,0.0003962445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009924188,"about_ca_system_score_gemma":0.001006123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007975177,"about_ca_topic_score_gemma":0.00293559,"domain_scores_codex":[0.9995731,0.0002139813,0.00003874591,0.00007037778,0.00005015533,0.00005366926],"domain_scores_gemma":[0.9996333,0.00006298261,0.00009702368,0.00003077902,0.00001878875,0.0001570358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4591105,0.01023297,0.05243094,0.002122497,0.002189692,0.001038531,0.0005775786,0.004850951,0.03673216,0.0004019139,0.008219798,0.4220925],"study_design_scores_gemma":[0.3045499,0.4796351,0.1641343,0.0002816268,0.002141136,0.004433637,0.000320228,0.005608272,0.01408312,0.0006589113,0.02405171,0.0001020554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894105,0.006516465,0.0003818047,0.0006483499,0.00006068758,0.0004914619,0.0006972313,0.00006092173,0.001732665],"genre_scores_gemma":[0.9945328,0.002005591,0.0008922175,0.0004079007,0.00005853005,0.0002804097,0.001060416,0.000008587665,0.0007534245],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001807463,"threshold_uncertainty_score":0.007200539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08724952197433244,"score_gpt":0.3742772388134105,"score_spread":0.2870277168390781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}